These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36075937)

  • 21. Evaluation of intraarterial and intravenous cisplatin chemotherapy in the treatment of metastatic osteosarcoma using an orthotopic xenograft mouse model.
    Robl B; Botter SM; Pellegrini G; Neklyudova O; Fuchs B
    J Exp Clin Cancer Res; 2016 Jul; 35(1):113. PubMed ID: 27421768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGF-β protects osteosarcoma cells from chemotherapeutic cytotoxicity in a SDH/HIF1α dependent manner.
    Xu Y; Li Y; Chen X; Xiang F; Deng Y; Li Z; Wei D
    BMC Cancer; 2021 Nov; 21(1):1200. PubMed ID: 34763667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ZD6474, a new treatment strategy for human osteosarcoma, and its potential synergistic effect with celecoxib.
    Liu J; Wu J; Zhou L; Pan C; Zhou Y; Du W; Chen JM; Zhu X; Shen J; Chen S; Liu RY; Huang W
    Oncotarget; 2015 Aug; 6(25):21341-52. PubMed ID: 26050198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells.
    Yang Q; Zhang S; Kang M; Dong R; Zhao J
    Oncol Rep; 2015 May; 33(5):2537-44. PubMed ID: 25738402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNAi-mediated knockdown of ERK1/2 inhibits cell proliferation and invasion and increases chemosensitivity to cisplatin in human osteosarcoma U2-OS cells in vitro.
    Si H; Peng C; Li J; Wang X; Zhai L; Li X; Li J
    Int J Oncol; 2012 Apr; 40(4):1291-7. PubMed ID: 22179790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diallyl trisulfide regulates cell apoptosis and invasion in human osteosarcoma U2OS cells through regulating PI3K/AKT/GSK3β signaling pathway.
    He P; Wang Z; Sheng B; Xu Y; Feng S; Huang Y; Gong F; Tang L; Xie L
    Histol Histopathol; 2020 Dec; 35(12):1511-1520. PubMed ID: 33372687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynasore suppresses cell proliferation, migration, and invasion and enhances the antitumor capacity of cisplatin via STAT3 pathway in osteosarcoma.
    Zhong B; Shi D; Wu F; Wang S; Hu H; Cheng C; Qing X; Huang X; Luo X; Zhang Z; Shao Z
    Cell Death Dis; 2019 Sep; 10(10):687. PubMed ID: 31534119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prexasertib (LY2606368) reduces clonogenic survival by inducing apoptosis in primary patient-derived osteosarcoma cells and synergizes with cisplatin and talazoparib.
    Heidler CL; Roth EK; Thiemann M; Blattmann C; Perez RL; Huber PE; Kovac M; Amthor B; Neu-Yilik G; Kulozik AE
    Int J Cancer; 2020 Aug; 147(4):1059-1070. PubMed ID: 31782150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selenocysteine inhibits human osteosarcoma cells growth through triggering mitochondrial dysfunction and ROS-mediated p53 phosphorylation.
    Wang W; Meng FB; Wang ZX; Li X; Zhou DS
    Cell Biol Int; 2018 May; 42(5):580-588. PubMed ID: 29323455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin induces apoptosis via upregulating Wrap53 in U-2OS osteosarcoma cells.
    Yuan JM; Li XD; Liu ZY; Hou GQ; Kang JH; Huang DY; Du SX
    Asian Pac J Cancer Prev; 2011; 12(12):3465-9. PubMed ID: 22471498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
    Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
    Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fructose-coated Angstrom silver inhibits osteosarcoma growth and metastasis via promoting ROS-dependent apoptosis through the alteration of glucose metabolism by inhibiting PDK.
    Hu XK; Rao SS; Tan YJ; Yin H; Luo MJ; Wang ZX; Zhou JH; Hong CG; Luo ZW; Du W; Wu B; Yan ZQ; He ZH; Liu ZZ; Cao J; Wang Y; Situ WY; Liu HM; Huang J; Wang YY; Xia K; Qian YX; Zhang Y; Yue T; Liu YW; Zhang HQ; Tang SY; Chen CY; Xie H
    Theranostics; 2020; 10(17):7710-7729. PubMed ID: 32685015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apigenin induces apoptosis through mitochondrial dysfunction in U-2 OS human osteosarcoma cells and inhibits osteosarcoma xenograft tumor growth in vivo.
    Lin CC; Chuang YJ; Yu CC; Yang JS; Lu CC; Chiang JH; Lin JP; Tang NY; Huang AC; Chung JG
    J Agric Food Chem; 2012 Nov; 60(45):11395-402. PubMed ID: 23066961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemosensitive effects of Astragaloside IV in osteosarcoma cells via induction of apoptosis and regulation of caspase-dependent Fas/FasL signaling.
    Hu T; Fei Z; Wei N
    Pharmacol Rep; 2017 Dec; 69(6):1159-1164. PubMed ID: 29128795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy.
    Kim M; Jung JY; Choi S; Lee H; Morales LD; Koh JT; Kim SH; Choi YD; Choi C; Slaga TJ; Kim WJ; Kim DJ
    Autophagy; 2017 Jan; 13(1):149-168. PubMed ID: 27754745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gallic acid induces the apoptosis of human osteosarcoma cells in vitro and in vivo via the regulation of mitogen-activated protein kinase pathways.
    Liang CZ; Zhang X; Li H; Tao YQ; Tao LJ; Yang ZR; Zhou XP; Shi ZL; Tao HM
    Cancer Biother Radiopharm; 2012 Dec; 27(10):701-10. PubMed ID: 22849560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin inhibits growth and sensitizes osteosarcoma cell lines to cisplatin through cell cycle modulation.
    Quattrini I; Conti A; Pazzaglia L; Novello C; Ferrari S; Picci P; Benassi MS
    Oncol Rep; 2014 Jan; 31(1):370-5. PubMed ID: 24253938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapamycin inhibits tumor growth of human osteosarcomas.
    Zhao S; Lu N; Chai Y; Yu X
    J BUON; 2015; 20(2):588-94. PubMed ID: 26011354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone methyltransferase SETD2 regulates osteosarcoma cell growth and chemosensitivity by suppressing Wnt/β-catenin signaling.
    Jiang C; He C; Wu Z; Li F; Xiao J
    Biochem Biophys Res Commun; 2018 Jul; 502(3):382-388. PubMed ID: 29842882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P-Glycoprotein Overexpression Is Associated With Cisplatin Resistance in Human Osteosarcoma.
    He C; Sun Z; Hoffman RM; Yang Z; Jiang Y; Wang L; Hao Y
    Anticancer Res; 2019 Apr; 39(4):1711-1718. PubMed ID: 30952710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.